US Patent Issued to KOBENHAVNS UNIVERSITET on Sept. 22 for "GLP1R agonist NMDAR antagonist conjugates" (Danish Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,006, issued on Sept. 22, was assigned to KOBENHAVNS UNIVERSITET (Copenhagen K, Denmark).

"GLP1R agonist NMDAR antagonist conjugates" was invented by Christoffer Clemmensen (Copenhagen K, Denmark), Anders Bue Klein (Copenhagen K, Denmark), Jonas Odgaard Petersen (Copenhagen K, Denmark), Bente Flensborg Frolund (Copenhagen K, Denmark) and Kristian Stromgaard (Copenhagen K, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "A conjugated molecule comprising a peptide displaying at least 0.1% activity of native glucagon-like peptide 1 (GLP-1) at the GLP-1 receptor, and an N-methyl-D-aspartate receptor (NMDAR) antagonist is provided. The peptide is c...